공간 오믹스 시장(2026-2030년)

The global spatial omics market is forecasted to grow by USD 932.0 mn during 2025-2030, accelerating at a CAGR of 15.6% during the forecast period. The report on the global spatial omics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for personalized medicine and high resolution single cell analysis, advancements in multiomics integration and automated bioinformatics, growing adoption of spatial biology in oncology and biomarker discovery.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global spatial omics market is segmented as below:

By Technology

• Spatial transcriptomics
• Spatial proteomics
• Spatial genomics
• Spatial metabolomics

By Product

• Consumables
• Instruments
• Software

By Application

• Drug discovery and development
• Cancer research
• Neuroscience
• Developmental biology
• Clinical research

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the transition toward clinical diagnostics and routine pathology as one of the prime reasons driving the global spatial omics market growth during the next few years. Also, emergence of 3d and live cell spatial profiling and shift toward decentralized and accessible benchtop instrumentation will lead to sizable demand in the market.

The report on the global spatial omics market covers the following areas:

• Global spatial omics market sizing
• Global spatial omics market forecast
• Global spatial omics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global spatial omics market vendors that include 10X Genomics Inc., Akoya Biosciences Inc., Bio Techne Corp., Bruker Corp., Curio Bioscience, Illumina Inc., Indica Labs LLC., LatchBio, Leica Biosystems Nussloch GmbH, Lunaphore, NanoString Technologies Inc., Nucleai.AI, PathAI Inc., Pixelgen Technologies, RareCyte Inc, Rebus Biosystems Inc, Resolve Biosciences, Spatial Genomics, Standard BioTools Inc., Ultivue Inc., Visiopharm AS, Vizgen Corp.. Also, the global spatial omics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Spatial Omics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Spatial Omics Market 2020 - 2024 ($ million)
• 5.2 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global spatial omics market
• 6.2 Impact of geopolitical conflicts on global spatial omics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Technology

• 8.1 Market segments
• 8.2 Comparison by Technology
• 8.3 Spatial transcriptomics - Market size and forecast 2025-2030
• 8.4 Spatial proteomics - Market size and forecast 2025-2030
• 8.5 Spatial genomics - Market size and forecast 2025-2030
• 8.6 Spatial metabolomics - Market size and forecast 2025-2030
• 8.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Consumables - Market size and forecast 2025-2030
• 9.4 Instruments - Market size and forecast 2025-2030
• 9.5 Software - Market size and forecast 2025-2030
• 9.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Drug discovery and development - Market size and forecast 2025-2030
• 10.4 Cancer research - Market size and forecast 2025-2030
• 10.5 Neuroscience - Market size and forecast 2025-2030
• 10.6 Developmental biology - Market size and forecast 2025-2030
• 10.7 Clinical research - Market size and forecast 2025-2030
• 10.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 UK - Market size and forecast 2025-2030
  • 12.4.2 Germany - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
  • 12.5.7 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 Brazil - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing demand for personalized medicine and high resolution single cell analysis
  • Advancements in multiomics integration and automated bioinformatics
  • Growing adoption of spatial biology in oncology and biomarker discovery
• 13.2 Market challenges
  • Prohibitive capital expenditure and high operational costs
  • Immense data complexity and infrastructure limitations
  • Lack of protocol standardization and sample preparation variability
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Transition toward clinical diagnostics and routine pathology
  • Emergence of 3D and live cell spatial profiling
  • Shift toward decentralized and accessible benchtop instrumentation

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 10X Genomics Inc.
  • 10X Genomics Inc. - Overview
  • 10X Genomics Inc. - Product / Service
  • 10X Genomics Inc. - Key offerings
  • SWOT
• 15.5 Akoya Biosciences Inc.
  • Akoya Biosciences Inc. - Overview
  • Akoya Biosciences Inc. - Product / Service
  • Akoya Biosciences Inc. - Key offerings
  • SWOT
• 15.6 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 15.7 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 15.8 Curio Bioscience
  • Curio Bioscience - Overview
  • Curio Bioscience - Product / Service
  • Curio Bioscience - Key offerings
  • SWOT
• 15.9 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
  • SWOT
• 15.10 Indica Labs LLC.
  • Indica Labs LLC. - Overview
  • Indica Labs LLC. - Product / Service
  • Indica Labs LLC. - Key offerings
  • SWOT
• 15.11 Leica Biosystems Nussloch GmbH
  • Leica Biosystems Nussloch GmbH - Overview
  • Leica Biosystems Nussloch GmbH - Product / Service
  • Leica Biosystems Nussloch GmbH - Key offerings
  • SWOT
• 15.12 Lunaphore
  • Lunaphore - Overview
  • Lunaphore - Product / Service
  • Lunaphore - Key offerings
  • SWOT
• 15.13 NanoString Technologies Inc.
  • NanoString Technologies Inc. - Overview
  • NanoString Technologies Inc. - Product / Service
  • NanoString Technologies Inc. - Key offerings
  • SWOT
• 15.14 PathAI Inc.
  • PathAI Inc. - Overview
  • PathAI Inc. - Product / Service
  • PathAI Inc. - Key offerings
  • SWOT
• 15.15 Resolve Biosciences
  • Resolve Biosciences - Overview
  • Resolve Biosciences - Product / Service
  • Resolve Biosciences - Key offerings
  • SWOT
• 15.16 Standard BioTools Inc.
  • Standard BioTools Inc. - Overview
  • Standard BioTools Inc. - Product / Service
  • Standard BioTools Inc. - Key offerings
  • SWOT
• 15.17 Visiopharm AS
  • Visiopharm AS - Overview
  • Visiopharm AS - Product / Service
  • Visiopharm AS - Key news
  • Visiopharm AS - Key offerings
  • SWOT
• 15.18 Vizgen Corp.
  • Vizgen Corp. - Overview
  • Vizgen Corp. - Product / Service
  • Vizgen Corp. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations